Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Leptospirosis meningitis transmission from a pet mouse: a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Microneedling in mature burn scars

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Presymptomatic diagnosis of Fabry's disease: a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Deadly pressure pneumothorax after withdrawal of misplaced feeding tube: a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  1. Vitamin D levels and Cancer Incidence in 217.244 individuals from Primary Health Care in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Chronic Non-bacterial Osteomyelitis: A Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Blood Pressure in Healthy Youngsters is modified by Vitamin-D Supplementation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The association of celiac disease and allergic disease in a general adult population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Sarah Byberg
  • Bo Abrahamsen
  • Moustapha Kassem
  • Stuart Ralston
  • Peter Schwarz
Vis graf over relationer

BACKGROUND: A 20-year-old Danish woman with melorheostosis in her right femoral shaft and disabling pain in the affected area, whose symptoms did not in the long term respond to zoledronic acid, experienced continuous remission of pain after treatment with denosumab. To the best of our knowledge, this is the first case report on denosumab treatment for melorheostosis.

CASE PRESENTATION: Radiologic findings and bone biopsy showed irregular cortical hyperostosis in the right femoral shaft with increased tracer uptake on Tc99-bone scan. The diagnosis of melorheostosis was made based on the radiological findings. There was a good initial response to zoledronic acid administration, but after relapse of pain, the second and third administrations had a poor effect. As a second line of treatment denosumab was administered at 8-week intervals, the frequency was based on our patient's symptoms and on biochemical markers of bone turnover.

CONCLUSION: This is the first report indicating that denosumab has a place in the treatment of melorheostosis when the effect of bisphosphonate treatment is insufficient.

OriginalsprogEngelsk
TidsskriftJournal of Medical Case Reports
Vol/bind12
Udgave nummer1
Sider (fra-til)278
ISSN1752-1947
DOI
StatusUdgivet - 2018

ID: 56483796